Jefferies Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,500
Closed -$698K 1439
2025
Q2
$698K Sell
2,500
-4,500
-64% -$1.27M 0.01% 820
2025
Q1
$2.18M Sell
7,000
-12,000
-63% -$3.54M 0.02% 554
2024
Q4
$4.95M Sell
19,000
-381,800
-95% -$113M 0.03% 367
2024
Q3
$129M Buy
400,800
+380,300
+1,855% +$124M 0.92% 18
2024
Q2
$6.41M Buy
20,500
+10,000
+95% +$2.94M 0.07% 229
2024
Q1
$2.99M Buy
10,500
+10,000
+2,000% +$2.93M 0.03% 451
2023
Q4
$144K Hold
500
﹤0.01% 1504
2023
Q3
$134K Sell
500
-2,500
-83% -$624K ﹤0.01% 1408
2023
Q2
$666K Sell
3,000
-68,700
-96% -$15.9M 0.01% 1073
2023
Q1
$17.3M Sell
71,700
-98,500
-58% -$24.2M 0.14% 126
2022
Q4
$44.7M Buy
+170,200
New +$45.6M 0.31% 48

Other funds holding AMGN

Jefferies Financial Group's AMGN Position: Q1 2026 in Review

Jefferies Financial Group increased its Amgen (AMGN) stake by 3.7% in Q1 2026, buying an estimated $1.39M and bringing the position to 108,330 shares worth $38.1M. The position accounts for 0.26% of the portfolio, ranked #65.

Jefferies Financial Group first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $130M in Q3 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Jefferies Financial Group held 108,330 shares of Amgen worth $38.1M as of Q1 2026.
  • Jefferies Financial Group bought 3,893 Amgen shares in Q1 2026, an estimated $1.39M.
  • Amgen made up 0.26% of Jefferies Financial Group's portfolio in Q1 2026, its #65 holding.
  • Jefferies Financial Group first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • Jefferies Financial Group's Amgen position peaked at $130M in Q3 2024.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.